Please login to the form below

Not currently logged in
Email:
Password:

Huntingdon Life Sciences appoints Joseph Bedford

He will serve as the firm's corporate VP forglobal strategic marketing

Huntingdon Life Sciences Harlan Laboratories Joseph BedfordHuntingdon Life Sciences and Harlan Laboratories have appointed Joseph Bedford as corporate vice president for global strategic marketing.

The two UK research firms already share a joint management structure and will later this year be merged under a single, yet-to-be-disclosed, brand. Bedford's newly-created role will see him head up a global team of 19 staff and sit on the firm's executive leadership team.

The job spans the company's contract research services (CRS) and research models services (RMS) business units, with responsibility for global marketing, business intelligence, strategic planning and some aspects of corporate development.

Dr Adrian Hardy, chief operating officer at Huntingdon Life Sciences and Harlan Laboratories, said: “We are delighted that Joe has joined the organisation. This is an especially important time for us as we continue to develop the combined, integrated brand of the two companies.

“Joe's strong expertise in strategic marketing across both the CRS and RMS CRO space will prove to be a great asset to the organisation, and he brings an experienced new voice to the team.”

Prior to joining Huntingdon and Harlan Bedford served as vice president of global marketing at Taconic Biosciences and he had stints with Covance, most recently as director of marketing and strategy, and the Almac Group, as director of marketing, over a twelve year period.

Commenting on his new role Bedford said: “I am very pleased to take on this position and look forward to playing my part in rebranding these two market leading companies and their subsidiaries to create a dynamic new firm that is well positioned for future growth.

“This is an ideal time to join the organisation given the enormous potential of the combined entity in the marketplace. We are already seeing the benefits of bringing these businesses together - it is exciting our customers, our employees and all the stakeholders in our new company.”

28th May 2015

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Conversis

Conversis is a translation company specialising in translation and localisation for the Life Science and Pharmaceutical industry, with particular focus...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics